Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Ahmadi Shahryar maintains a company patent portfolio in the Biotechnology & Pharmaceuticals technology area. The portfolio is currently navigating 1 pending office action. This 1 pending office action is the only active matter for the portfolio, suggesting a focused effort on a specific technical filing.
The prosecution is overseen by 1 distinct examiner and 1 distinct art unit. This concentration indicates that the innovations are being reviewed within a single technical division by a single individual. For the practitioner, the 1 distinct examiner and 1 distinct art unit provide a consistent environment where the prosecution strategy can be refined for a single audience without competing procedural requirements.
HAWTHORNE, OPHELIA ALTHEA is the busiest examiner, managing 1 busiest examiner pending office action. Because HAWTHORNE, OPHELIA ALTHEA is the only examiner involved, the success of the 1 pending office action depends entirely on this individual's assessment. Practitioners should focus on the specific examination patterns of HAWTHORNE, OPHELIA ALTHEA to move the portfolio forward effectively.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §112 only | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| HAWTHORNE, OPHELIA ALTHEA | 1 | 72.0% | +30.2% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18750626 | TOPICAL WOUND DRESSINGS AND METHODS FOR USE THEREOF | HAWTHORNE, OPHELIA ALTHEA | — |
| Art Unit | Apps |
|---|---|
| 1699 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18750626 | TOPICAL WOUND DRESSINGS AND METHODS FOR USE THEREOF | HAWTHORNE, OPHELIA ALTHEA | 1699 | §112 | Non-Final OA | — | Pending | Jun 21, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialAhmadi Shahryar has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Ophelia Althea Hawthorne has the most, with 1 of Ahmadi Shahryar's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
